PLAB
Photronics, Inc.
PLAB's outlook is improving, though it still trails on the overall score.
PLTR
Palantir Technologies Inc.
PLTR has the edge over PLAB overall, supported by stronger fundamentals and stronger modeled upside.
PLAB Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Strong |
PLAB's profitability, cash flow and balance sheet are currently strong, and its revenue is stable.
PLTR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
PLTR's revenue, profitability, cash flow and balance sheet are all currently strong.
PLAB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 9.9x | $27.88 | — |
| Cheap | 10x | $28.49 | +2.2% |
| Fair | 13x | $37.09 | +33% |
| Forward | 13x | $27.88 | — |
| Expensive | 22x | $62.33 | +124% |
Historical ranges are pointers, not guarantees.
PLAB's PE is in its cheap range at 9.8x. On analysts' estimates for next year's earnings, today's price would be 13x, in its fair range.
PLTR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 75x | $172 | — |
| Current | 120x | $172 | — |
| Cheap | 165x | $236 | +37% |
| Fair | 251x | $359 | +109% |
| Expensive | 452x | $646 | +277% |
Historical ranges are pointers, not guarantees.
PLTR has the edge over PLAB in the historical PE scenario, which offers more potential upside but is not a forecast.
PLAB Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect PLAB's earnings to grow and its profitability to improve, with its revenue holding steady.
PLTR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
PLTR has the edge over PLAB on the outlook, with more favorable valuation and revenue expectations.
PLAB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.09 | -26% |
| Q3 2026 | $2.83 | +61% |
| Q2 2026 | $2.73 | +42% |
| Q1 2026 | $2.34 | -0.4% |
| Q4 2025 | $2.28 | +9.1% |
| Q3 2025 | $1.76 | -22% |
| Q2 2025 | $1.92 | -11% |
| Q1 2025 | $2.35 | +5.9% |
| Q4 2024 | $2.09 | +3% |
PLAB earned $2.83 per share over the past year, up 61% from the year before.
PLTR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.30 | +61% |
| Q3 2026 | $1.43 | +240% |
| Q2 2026 | $1.17 | +290% |
| Q1 2026 | $0.89 | +287% |
| Q4 2025 | $0.63 | +232% |
| Q3 2025 | $0.42 | +110% |
| Q2 2025 | $0.30 | +76% |
| Q1 2025 | $0.23 | +92% |
| Q4 2024 | $0.19 | +111% |
PLTR has the edge over PLAB on earnings, with more consistent year-over-year improvement.
PLAB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $216M | +2.7% |
| Q2 2026 | $209.9M | -0.5% |
| Q1 2026 | $225.1M | +6.1% |
| Q4 2025 | $215.8M | -3.1% |
| Q3 2025 | $210.4M | -0.3% |
| Q2 2025 | $211M | -2.8% |
| Q1 2025 | $212.1M | -1.9% |
| Q4 2024 | $222.6M | -2.1% |
PLAB's revenue grew through 2022 and has held roughly level since: $216M last quarter, up 2.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 21% | -1.8 points |
| Q2 2026 | 20% | -6.3 points |
| Q1 2026 | 24% | -0.2 points |
| Q4 2025 | 24% | -0.9 points |
| Q3 2025 | 23% | -1.8 points |
| Q2 2025 | 26% | +0.6 points |
| Q1 2025 | 25% | -2 points |
| Q4 2024 | 25% | -3.4 points |
PLAB's operating margin was 21% last quarter, down 1.8 points from the same quarter a year ago.
PLTR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.3B | +96% |
| Q2 2026 | $1.9B | +93% |
| Q1 2026 | $1.6B | +85% |
| Q4 2025 | $1.4B | +70% |
| Q3 2025 | $1.2B | +63% |
| Q2 2025 | $1B | +48% |
| Q1 2025 | $883.9M | +39% |
| Q4 2024 | $827.5M | +36% |
PLTR has the edge over PLAB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 47% | +14 points |
| Q2 2026 | 47% | +20 points |
| Q1 2026 | 46% | +26 points |
| Q4 2025 | 41% | +40 points |
| Q3 2025 | 33% | +18 points |
| Q2 2025 | 27% | +11 points |
| Q1 2025 | 20% | +7.2 points |
| Q4 2024 | 1.3% | -9.5 points |
PLTR has the edge over PLAB on profitability, with a higher operating margin.
PLAB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $39.4M | +56% |
| Q2 2026 | $1.2M | +$30.3M |
| Q1 2026 | $49.6M | +15% |
| Q4 2025 | $20.3M | -19% |
| Q3 2025 | $25.2M | -50% |
| Q2 2025 | -$29.1M | -152% |
| Q1 2025 | $43.3M | +$45.1M |
| Q4 2024 | $25.2M | -54% |
PLAB still generates free cash flow, though less than at its 2022 peak: $110M over the past year.
PLTR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.2B | +139% |
| Q2 2026 | $1.2B | +126% |
| Q1 2026 | $891.8M | +193% |
| Q4 2025 | $764M | +67% |
| Q3 2025 | $500.9M | +20% |
| Q2 2025 | $531.6M | +276% |
| Q1 2025 | $304.1M | +140% |
| Q4 2024 | $457.2M | +54% |
PLTR has the edge over PLAB on cash flow, with more consistent year-over-year improvement.
PLAB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -27K shares |
| 1 year | +1.1% | +650K shares |
| 3 years | -5.3% | -3.3M shares |
| 5 years | -4.5% | -2.8M shares |
| Available history | -15% | -10.4M shares |
PLAB has 59M diluted shares, up 1.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $20.7M |
| Q2 2025 | $72.1M |
| Q1 2025 | $4.6M |
| Q4 2023 | — |
PLAB hasn't bought back shares in the past year.
PLTR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +5.2M shares |
| 1 year | +0.1% | +2.9M shares |
| 3 years | +11% | +248M shares |
| 5 years | +31% | +610M shares |
| Available history | +184% | +1.7B shares |
PLTR has the edge over PLAB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $19.2M |
| Q3 2025 | $19.2M |
| Q2 2025 | $18.6M |
| Q1 2025 | $18M |
| Q4 2024 | $18.6M |
| Q3 2024 | $18.9M |
| Q2 2024 | $17.7M |
| Q1 2024 | $9M |
PLAB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.0x | Net Cash |
| Q2 2026 | -1.9x | Net Cash |
| Q1 2026 | -1.9x | Net Cash |
| Q4 2025 | -1.7x | Net Cash |
| Q3 2025 | -1.6x | Net Cash |
| Q2 2025 | -1.8x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -1.9x | Net Cash |
PLAB has the edge over PLTR on leverage, with a lower net debt burden relative to earnings.
PLTR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -1.1x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q3 2025 | -1.9x | Net Cash |
| Q2 2025 | -1.6x | Net Cash |
| Q1 2025 | -2.3x | Net Cash |
| Q4 2024 | -6.1x | Net Cash |
PLTR has more cash than debt.
PLAB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.6 | Neutral |
| Stochastic | 15.9 | Oversold |
PLAB's weekly RSI is 43 (neutral) and its Stochastic is 16 (oversold).
PLTR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.4 | Neutral |
| Stochastic | 47.4 | Neutral |
PLTR's weekly RSI is 51 (neutral) and its Stochastic is 47 (neutral).
PLAB PE vs Technology Sector
| Metric | PLAB | Sector median | Relative |
|---|---|---|---|
| PE | 9.9x | 28x | 65% below |
| PE % | 14 | 35 | 21 pts below |
PLAB has the edge over PLTR on valuation relative to its sector.
PLTR PE vs Technology Sector
| Metric | PLTR | Sector median | Relative |
|---|---|---|---|
| PE | 120x | 28x | 331% above |
| PE % | 1 | 38 | 37 pts below |
PLTR is trading at 120x earnings, a 331% premium to the Technology sector's median of 28x.
PLAB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $28.8 | 3% below |
| 20 week MA | $29.5 | 5.4% below |
| 50 week MA | $34.6 | 19% below |
| 100 week MA | $27.9 | 0.1% below |
| 200 week MA | $25.7 | 8.3% above |
PLAB has fallen below most of its moving averages, though it's still 8.3% above its 200-week average.
PLTR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $185.8 | 7.6% below |
| 20 week MA | $167.6 | 2.4% above |
| 50 week MA | $157.1 | 9.2% above |
| 100 week MA | $143.8 | 19% above |
| 200 week MA | $83.3 | 106% above |
PLTR has the edge over PLAB on trend strength, trading above more of its moving averages.
PLAB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.8 | $11.0 | -30% |
| 2021 | $11.0 | $18.5 | +68% |
| 2022 | $18.5 | $16.4 | -11% |
| 2023 | $16.4 | $31.4 | +91% |
| 2024 | $31.4 | $23.9 | -24% |
| 2025 | $23.9 | $33.7 | +41% |
| 2026 YTD | $33.7 | $27.9 | -17% |
PLAB has finished lower in three of the last six years. It's down 17% so far in 2026.
PLTR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.20 | $27.8 | +202% |
| 2021 | $27.8 | $18.9 | -32% |
| 2022 | $18.9 | $6.29 | -67% |
| 2023 | $6.29 | $17.2 | +173% |
| 2024 | $17.2 | $79.1 | +361% |
| 2025 | $79.1 | $188.7 | +139% |
| 2026 YTD | $188.7 | $171.6 | -9.1% |
PLTR has the edge over PLAB on returns for 2026, with the stronger performance.